Advanced therapeutic and prophylactic strategies for Epstein–Barr virus infection in immunocompromised patients
M Okano, TG Gross - Expert Review of Anti-Infective Therapy, 2007 - Taylor & Francis
Epstein–Barr virus (EBV) is an ubiquitous human herpesvirus. Primary infection is generally
subclinical but in certain circumstances, such as in patients with either hereditary or …
subclinical but in certain circumstances, such as in patients with either hereditary or …
The evolving therapeutic approaches for Epstein-Barr virus infection in immunocompetent and immunocompromised individuals
M Okano - Current Drug Targets-Immune, Endocrine & …, 2003 - ingentaconnect.com
Epstein-Barr virus (EBV) is one of eight known human herpesviruses (HHVs). A primary EBV
infection is generally subclinical in immunocompetent individuals, but often causes …
infection is generally subclinical in immunocompetent individuals, but often causes …
Progress and problems in understanding and managing primary Epstein-Barr virus infections
OA Odumade, KA Hogquist… - Clinical microbiology …, 2011 - Am Soc Microbiol
Epstein-Barr virus (EBV) is a gammaherpesvirus that infects a large fraction of the human
population. Primary infection is often asymptomatic but results in lifelong infection, which is …
population. Primary infection is often asymptomatic but results in lifelong infection, which is …
Prophylactic and therapeutic strategies for Epstein–Barr virus-associated diseases: emerging strategies for clinical development
ABSTRACT Introduction: Epstein–Barr virus (EBV) infects more than 95% of the world's
population and is associated with infectious mononucleosis as well as a number of cancers …
population and is associated with infectious mononucleosis as well as a number of cancers …
Immunological aspects of Epstein–Barr virus infection
S Ohga, A Nomura, H Takada, T Hara - Critical reviews in oncology …, 2002 - Elsevier
Epstein–Barr virus (EBV) is a member of ubiquitous γ herpes viruses, which primarily
induces acute infectious mononucleosis (IM) or subclinical infection in susceptible subjects …
induces acute infectious mononucleosis (IM) or subclinical infection in susceptible subjects …
Immune regulation in Epstein-Barr virus-associated diseases
R Khanna, SR Burrows, DJ Moss - Microbiological reviews, 1995 - Am Soc Microbiol
Epstein-Barr virus (EBV) is a member of the human herpesvirus family and, like many other
herpesviruses, maintains a lifelong latent association with B lymphocytes and a permissive …
herpesviruses, maintains a lifelong latent association with B lymphocytes and a permissive …
[HTML][HTML] Epstein Barr virus: development of vaccines and immune cell therapy for EBV-associated diseases
X Cui, CM Snapper - Frontiers in Immunology, 2021 - frontiersin.org
Epstein-Barr virus (EBV) is the first human tumor virus discovered and is strongly implicated
in the etiology of multiple lymphoid and epithelial cancers. Each year EBV associated …
in the etiology of multiple lymphoid and epithelial cancers. Each year EBV associated …
An overview of epstein-barr virus: from discovery to future directions for treatment and prevention.
J Andersson - Herpes: the journal of the IHMF, 2000 - europepmc.org
Discovered in 1964 by Epstein and Barr, the Epstein-Barr virus (EBV) is widespread in all
areas of the world, infecting over 95% of the adult population and earning it the informal …
areas of the world, infecting over 95% of the adult population and earning it the informal …
Epstein-Barr virus: the impact of scientific advances on clinical practice
H Williams, DH Crawford - Blood, 2006 - ashpublications.org
Epstein-Barr virus (EBV) is a tumorigenic herpes virus that infects and persists in B
lymphocytes in the majority of humans, generally without causing disease. However, in a …
lymphocytes in the majority of humans, generally without causing disease. However, in a …
Immune evasion by Epstein-Barr virus
ME Ressing, M van Gent, AM Gram… - Epstein Barr Virus …, 2015 - Springer
Epstein-Bar virus (EBV) is widespread within the human population with over 90% of adults
being infected. In response to primary EBV infection, the host mounts an antiviral immune …
being infected. In response to primary EBV infection, the host mounts an antiviral immune …
相关搜索
- strategies for epstein immunocompromised patients
- epstein barr virus infection
- epstein barr scientific advances
- strategies for epstein clinical development
- epstein barr immune evasion
- epstein barr treatment and prevention
- epstein barr clinical practice
- epstein barr problems in understanding
- epstein barr immune regulation